Oasmia

Oasmia launches the ovarian cancer treatment drug Apealea® in Sweden, Denmark and Finland

Read more
Oasmia and Elevar sign a global strategic partnership for the commercialization of Apealea®

Press release

Audiocast
Year-end Report 2019 / 2020

Read the report
Analysguiden: Interview with Oasmia

30 juli, 2020

Watch the interview

Press releases

August 10, 2020 Regulatory press release
Notice of Annual General Meeting in Oasmia Pharmaceutical AB
August 10, 2020
Oasmia Pharmaceutical Appoints Peter Selin as Chief Business Officer
July 27, 2020 Regulatory press release
Oasmia’s partner Elevar Therapeutics and Tanner Pharma Announce Global Named Patient Program to Provide Access to Apealea®

All press releases

Financial reports

Calendar

August 17 - August 21, 2020 Annual Report 2019 / 2020
September 9, 2020 14:00 CET Annual General Meeting 2020
September 9, 2020 Interim Report May – July 2020

The Share

Follow the share

We uses cookies in order to optimize your use of our website. Read more about cookies.

OK